Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 3.34
0.3 %
$ 420 M
Market Cap
-66.8
P/E
Price Target
Average
49.70%
Revenue Forecast
Estimate
17.89%
EBIT
Estimate
58.69%
Net Income
Estimate
165.69%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Organogenesis Holdings Inc.
Wall Street analysts predict an average 1-year price target for ORGO of $5 , with forecasts ranging from
a
low of
$5 to a high of $5 .
ORGO Lowest Price Target
Wall Street Target
5 USD
49.70%
ORGO Average Price Target
Wall Street Target
5 USD
49.70%
ORGO Highest Price Target
Wall Street Target
5 USD
49.70%
REVENUE FORECAST
Revenue Forecast Chart ORGO
EBIT FORECAST
EBIT Forecast Chart ORGO
NET INCOME FORECAST
Net Income Chart ORGO